2021 ACMT Symposium | The 4th Wave: Methamphetamines & Stimulants

The American College of Medical Toxicology (ACMT) invites you to join them at their one-day virtual symposium entitled "The 4th Wave: Methamphetamines & Stimulants" on Tuesday, April 13, 2021. This symposium aims to examine the current trends of methamphetamine use, abuse, and co-use with other illicit substances. Multiple innovative research initiatives will be discussed highlighting some of the work of the Methamphetamine Research Center in Portland, Oregon. Multiple speakers on topics ranging from pregnancy and methamphetamine use, stimulant abuse in children, psychiatric effects of methamphetamine, and the approach to the agitated patient will be covered. The symposium will close with discussions on the challenges with treatment of the methamphetamine addiction. This activity will appeal to healthcare providers and researchers involved with care of patients with substance use disorders.

Preliminary Agenda - Tuesday, April 13, 2021 - All Times Listed in Eastern Time Zone (ET)

9:45 - 10:00 AM ET	Welcome & Introductions Paul M. Wax, MD, FACMT, Professor, Emergency Medicine, UT-Southwestern; Executive Director, American College of Medical Toxicology Kathryn T. Kopec, DO, Associate Professor of Emergency Medicine, Emergency Medicine and Medical Toxicologist; Atrium Health's Carolinas Medical Center, Charlotte, NC
10:00 - 10:20 AM ET	Methamphetamines & Stimulants: How did we get here? Paul M. Wax, MD, FACMT, Professor, Emergency Medicine, UT-Southwestern; Executive Director, American College of Medical Toxicology
10:20 - 10:50 AM ET	Real Time Communication Network: Identifying Stimulants in Your Neighborhood Agnes D. Winokur, MS, Associate Laboratory Director, Drug Enforcement Agency/Southeast Laboratory, U.S. Department of Justice, Miami, FL
10:50 - 11:20 AM ET	Emerging Trends in Stimulant Use Josh G. Schier, MD, FACMT, Medical Toxicologist Associate Director, Emory/CDC Medical Toxicology Fellowship, Assistant Professor, Department of Emergency Medicine, Emory University School of Medicine, Atlanta, GA
11:20 - 11:30 AM ET	Break
11:30 - 12:00 PM ET	Neural Network Connectivity and the Role of Opioid Receptor Antagonism in Methamphetamine Dependence Milky Kohno, PhD, Research Scientist, Portland VA Medical Center; Assistant Professor, Psychiatry and Behavioral Neuroscience, Oregon Health & Science University, Portland, OR
12:00 - 12:30 PM ET	Factors That Impact Risk for Methamphetamine Addiction Tamara J. Phillips, PhD, Senior Research Career Scientist, Portland VA Medical Center; Professor, Psychiatry and Behavioral Neuroscience, Oregon Health & Science University, Portland, OR
12:30 - 12:40 PM ET	Break
12:40 - 1:10 PM ET	TAAR1 and Methamphetamine Use Disorder in Humans William Hoffman, MD, PhD, Staff Psychiatrist, Mental Health and Clinical Neurosciences Division, Portland VA Medical Center; Professor, Psychiatry and Behavioral Neuroscience, Oregon Health and Science University, Portland, OR
1:10 - 1:40 PM ET	Neuroinflammation and Treatments of the Future Jennifer M. Loftis, PhD, Research Scientist, Portland VA Medical Center; Professor, Psychiatry and Behavioral Neuroscience, Oregon Health and Science University, Portland, OR
1:40 - 2:10 PM ET	Lunch Break
2:10 - 2:30 PM ET	Methamphetamine Use and Pregnancy Lindsay K. Admon, MD, MSc, Assistant Professor, Obstetrics and Gynecology, Institute for Healthcare Policy & Innovation, University of Michigan, Ann Arbor, MI
2:30 - 2:50 PM ET	Methamphetamine in Children Ayrn D. O'Connor, MD, FACMT, FAAEM, Director, Medical Toxicology Fellowship, University of Arizona College of Medicine Phoenix Banner -- University Medical Center Phoenix, Phoenix, AZ
2:50 - 3:10 PM ET	So You've Filed a Child Protective Services Report: Now What? Patience Pearson, LMSW, Addiction Medicine Social Worker, Banner University Medical Center, Phoenix, AZ
3:10 - 3:30 PM ET	Meth and the Mind: Psychiatric Effects of Methamphetamine Stephanie T. Weiss, MD, PhD, Addiction Medicine Research Fellow, Wake Forest Baptist Medical Center, Winston-Salem, NC
3:30 - 4:20 PM ET	Panel Discussion: The Agitated Patient Jon B. Cole, MD, FACMT, Associate Professor of Emergency Medicine, Hennepin Healthcare-Minneapolis; Medical Director, Minnesota Poison Control System, Minneapolis, MN Andrew I. Stolbach, MD, MPH, FACMT, Associate Professor of Emergency Medicine, Johns Hopkins Hospital, Baltimore, MD Caitlin F. Bonney, MD, FACMT, Assistant Professor of Emergency Medicine, Toxicology Director, University Medical Center of Southern Nevada, Las Vegas, NV Stacey Hail, MD, FACMT, Associate Professor of Emergency Medicine and Medical Toxicology, University of Texas Southwestern Medical Center, Dallas, TX
4:20 - 4:30 PM ET	Break
4:30 - 4:50 PM ET	Developing Antibody-Based Therapies for Methamphetamine Abuse Eric C. Peterson, PhD, Associate Professor, Department of Pharmacology and Toxicology, University of Arkansas College of Medicine, Little Rock, AR
4:50 - 5:10 PM ET	Innovations in Treatment of Methamphetamine Use Disorder Todd Korthuis, MD, MPH, Professor of Medicine, Program Director of Addiction Medicine Fellowship and Co-Director of the Oregon Addiction Education and Prevention Initiative, Oregon Health & Science University, Portland, OR
5:10 - 5:40PM ET	Social Aspects of Stimulant Use Brian L. Chan, MD, MPH, Instructor of Medicine, Division of General Internal Medicine and Geriatrics, Oregon Health and Science University, Portland, OR Stacey Hail, MD, FACMT, Associate Professor of Emergency Medicine and Medical Toxicology, University of Texas Southwestern Medical Center, Dallas, TX
5:40 - 6:20 PM ET	Panel Discussion: Challenges Associated with Treating Stimulant Use Disorder Amanda Risser, MD, MPH, Senior Medical Director of Substance Use Disorder Services, Family Medicine Specialist, Public Health & General Preventive Medicine; Legacy Emanuel Medical Center; Oregon Health and Science University Hospital, Portland, OR Brian L. Chan, MD, MPH, Instructor of Medicine, Division of General Internal Medicine and Geriatrics; Oregon Health and Science University, Portland, OR Guest Speaker: Special Perspective from a Former Addict

Fees & Registration

EXTENDED! Early Bird Rates* Deadline: March 18, 2021		Regular Rates March 19, 2021 - April 13, 2021
Registration Category	Fee	Registration Category	Fee
ACMT Member	$195	ACMT Member	$250
Fellow-in-Training	$150	Fellow-in-Training	$200
Resident	$150	Resident	$200
Student	$125	Student	$175
Specialist in Poison Information (SPI)	$150	Specialist in Poison Information (SPI)	$200
Non-Member: Government & Military Personnel	$195	Non-Member: Government & Military Personnel	$250
Non-Member	$295	Non-Member	$325
Continuing Medical Education	$75	Continuing Medical Education	$75

*Early Bird Rates expire at 11:59 PM on March 18, 2021. Fees increase to the Regular Rate after this date, no exceptions.

**Proof of student and resident status is required to confirm this rate. Proof consists of a copy of your student ID or a letter from your institution’s Registrar verifying student or resident status. Documentation must be received within two weeks of registering via email to info@acmt.net or fax to (844) 226-8333. Attention: 2021 ASM.

Cancellation Policy: Cancellations received in writing on or prior to March 4, 2021 are subject to a $150 processing fee. Refunds will not be granted after March 4, 2021. Please send cancellation request to ACMT at info@acmt.net, or fax to 623-533-6520.

Event Details

The 2021 ACMT Symposium will be a virtual event that takes place online. Registrants will receive an email with instructions on how to access the virtual event platform closer to the event in April 2021. All sessions will be recorded and made available to registrants after the event for on-demand viewing.

Questions?

Write to: info@acmt.net